RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. ATEM Capital Fund LP
A

ATEM Capital Fund LP portfolio

ATEM Capital Fund LP has 2 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $45M.
Latest deal: Triumvira Immunologics · Mar 17, 2022.
About this page

Its most recent investment on record is Triumvira Immunologics's $45M Series A round in March 2022, alongside Multiple Myeloma Research Foundation, Leaps by Bayer, Myeloma Investment Fund and 2 others. By category, its portfolio leans toward Health and bio (2).

What ATEM Capital Fund LP invests in

How ATEM Capital Fund LP invests

StageDealsCapital in rounds
Series A 1 100%$45M

ATEM Capital Fund LP portfolio companies

CompanyRound with ATEM Capital Fund LPTotal raisedLatest raise
TTriumvira Immunologics
Health and bio
Series A · $45M$100MMar 17, 2022
Series A
PPGxAI
Health and bio
backerundisclosedSep 14, 2026
Seed

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name ATEM Capital Fund LP. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists ATEM Capital Fund LP, which is a subset of its real portfolio. API: /api/v1/investors/atem-capital-fund-lp (get a free API key). More: the most active VC firms and new venture capital funds.